Evaluation of allergen vaccine potency

Current Allergy and Asthma Reports

Volumn 6, Issue 5, 2006, Pages 402-406

  Esch, Robert E ^a  

^a Greer Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALLERGEN VACCINE; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VACCINE;

ACCURACY; ACTIVE IMMUNIZATION; ALLERGY; DRUG DETERMINATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNODIFFUSION; IN VITRO STUDY; IN VIVO STUDY; RELIABILITY; REVIEW; SKIN TEST; STANDARD; STANDARDIZATION; VALIDATION PROCESS;

ALLERGENS; BIOLOGICAL ASSAY; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; REFERENCE STANDARDS; THERAPEUTIC EQUIVALENCY; VACCINES;

EID: 33748438830     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-996-0013-8     Document Type: Review

References (40)

1. Morrow KS, Slater JE: Regulatory aspects of allergen vaccines in the US. Clin Rev Allergy Immunol 2001, 21:141-152.
2. Grier TJ: Laboratory methods for allergen extract analysis and quality control. Clin Rev Allergy Immunol 2001, 21:111-140.
3. Noon L: Prophylactic inoculation against hay fever. Lancet 1911, i:1572-1573.
4. May JC, Sih JT, Miller JR, Seligmann EB Jr: Optimization of parameters in protein nitrogen unit precipitation procedure for allergenic extracts. J Allergy Clin Immunol 1979, 63:87-97.
5. Turkeltaub PC: Biological standardization. Arb Paul Ehrlich Institut 1997, 91:145-156.
6. Turkeltaub PC, Rastogi SC, Baer H, et al.: A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol 1982, 70:343-352.
7. Malling HJ: Skin prick testing in biological standardization of allergenic products. Arb Paul Ehrlich Institut 1997, 91:157-163.
8. Dreborg S: Precision of biological standardization of allergenic preparations. Allergy 1992, 47:291-294.
9. Dreborg S, Sjogren I, Eriksson NE, Einarsson R: Selection of patients for biological standardization as exemplified by standardization of mugwort, goosefoot and English plantain pollen allergen extracts/ preparations. Allergy 1987, 42:485-495.
10. Rabin RL, Slater JE, Lachenbrunch P, Pastor RW: Sample size considerations for establishing bioequivalence of allergen formulations. Arb Paul Ehrlich Institut 2002, 94:24-33.
11. Casas R, Ferrandiz R, Wihl JA, et al.: Biologic activity of Dermatophagoides siboney and Blomia tropicalis allergens in exposed and unexposed mite-allergic individuals. Effect of patient selection on the biologic standardization of mite extracts. Allergy 1999, 54:392-396.
12. Cromwell O, Weber B, Kahlert H, Fiebig H: Standardization in quality control of modified end-products. Arb Paul Ehrlich Insitut 1999, 93:93-100.
13. Ibarrola I, Sanz ML, Gamboa PM, et al.: Biological characteristization of gluaraldehyde-modified Parietaria judaica pollen extracts. Clin Exp Allergy 2004, 34:303-309.
14. Ferreira F, Briza P, Infuhr D, et al.: Modified recombinant allergen for safer immunotherapy. Inflamm Allergy Drug Targets 2006 5:5-14.
15. Niederberger V, Valenta R: Molecular approaches for new vaccines against allergy. Expert Rev Vaccines 2006, 5:103-110.
16. Alexander C, Kay AB, Larche M: Peptide-based vaccines in the treatment of specific allergy. Curr Drug Targets Inflamm Allergy 2002, 1:353-361.
17. Turkeltaub PC: Allergen vaccine unitage based on biological standardization: clinical significance. In Allergen and Allergen Immunotherapy. Edited by Lockey R, Bukantz SC. New York: Marcel Dekker; 1999:321-340.
18. Food and Drug Administration: ELISA competition assay: quantitative determination of relative potency of allergenic extracts. In Methods of the Allergenic Products Testing Laboratory. CBER/FDA; 1998.
19. Esch RE: Allergen source materials and quality control of allergenic extracts. Methods 1997, 13:2-13.
20. Dobrovolskaia E, Gam A, Slater JE: Competition enzyme-linked immunosorbent assay (ELISA) can be a sensitive method for the specific detection of small quantities of allergen in a complex mixture. Clin Exp Allergy 2006, 36:525-530.
21. Afferni C, Pini C, Tinghino R, et al.: Use of monoclonal antibodies in the standardization of Parietaria judaica allergenic extracts. Biologicals 1995, 23:239-247.
22. Kaul S, Scheurer S, Danz N, et al.: Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological standardization of allergens. J Allergy Clin Immunol 2003, 111:1262-1268.
23. Vogel L, Luttkopf D, Hatahet L, et al.: Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 2005, 60:1021-1028.
24. Baer H, Godfrey H, Maloney CJ, et al.: The potency and antigen E content of commercially prepared ragweed extracts. J Allergy 1970, 45:347-354.
25. Baer H, Maloney CJ, Norman PS, Marsh DG: The potency and Group I antigen content of six commercially prepared grass pollen extracts. J Allergy Clin Immunol 1974, 54:157-164.
26. Anderson MC, Baer H: Allergenically active components of cat allergen extracts. J Immunol 1981, 127:972-975.
27. Duffort O, Calabozo B, Gonzalez R, et al.: Monoclonal antibody-based ELISA to quantify the major allergen of Cynodon dactylon (Bermuda grass) pollen, Cyn d 1. Int Arch Allergy Immunol 2004, 135:277-283.
28. Ramirez J, Obispo TM, Duffort D, et al.: Group 5 determination in Pooideae grass pollen extracts by monoclonal antibody-based ELISA. Correlation with biologic activity. Allergy 1997, 52:806-813.
29. Jimeno L, Duffort O, Serrano C, et al.: Monoclonal antibody-based ELISA to quantify the major allergen of Artemisia vulgaris pollen, Art v 1. Allergy 2004, 59:995-1001.
30. Arilla MC, Eraso E, Ibarrola I, et al.: Monoclonal antibody-based method measuring olive pollen major allergen Ole e 1. Ann Allergy Asthma Immunol 2002, 89:83-89.
31. Arilla, MC, Ibarrola I, Garcia R, et al.: Quantification of the major allergen from cypress (Cupressus arizonica) pollen, Cup a 1, by monoclonal antibody-based ELISA. Int Arch Allergy Immunol 2004, 134:10-16.
32. Arilla MC, Ibarrola I, Mir A, et al.: Development of a sandwich-type ELISA for measuring Pla a 1, the major allergen of Platanus acerifolia pollen. Int Arch Allergy Immunol 2005, 138:127-133.
33. Yi FC, Lee BW, Cheong N, Chua KY: Quantification of Blot t 5 in mite and dust extracts by two-site ELISA. Allergy 2005, 60:108-112.
34. Jimeno L, Duffort O, Serrano C, et al.: Monoclonal antibody-based ELISA to quantify the major allergen of Artemisia vulgaris pollen, Art v 1. Allergy 2004, 59:995-1001.
35. Arilla MC, Gonzalez-Rioja R, Ibarrola I, et al.: A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2. Clin Exp Allergy 2006, 36:87-93.
36. Portnoy J, Pacheco F, Upadrasthta, Barnes C: A double monoclonal antibody assay for the Alternaria allergen GP70. Ann Allergy 1993, 71:401-407.
37. Vailes L, Sridhara S, Cromwell O, et al.: Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001, 107-641-646.
38. Grier TJ, Hazelhurst DM, Duncan EA, et al.: Major allergen measurements: sources of variability, validation, quality assurance, and utility for laboratories, manufacturers, and clinics. Allergy Asthma Proc 2002, 23:125-131.
39. Esch RE: Manufacturing and standardizing fungal allergen products. J Allergy Clin Immunol 2004, 113:210-215.
40. van Ree R, Dorpema JW, Veiths S: Allergy vaccines: a need for standardization in mass units of major allergen. Pharmeuropa Bio 2005, 1:27-30.